3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Dermatologic
3
Sarcoma
1
Conditions
Dermatofibrosarcoma
2
Skin Neoplasms
1
Neoplasms, Adnexal and Skin Appendage
1
Melanoma
1
Histiocytoma, Malignant Fibrous
1
Carcinoma, Squamous Cell
1
Carcinoma, Basal Cell
1
Interventions
pembrolizumab
3
talimogene laherparepvec
1
spartalizumab
1
daromun
1
avelumab
1
Therapeutics
1
TTI-621
1
Radiation, Ionizing
1
Radiation
1
Proton Pump Inhibitors
1
Nivolumab
1
Mohs Surgery
1
Ipilimumab
1
Hydrocortisone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinoma, Squamous Cell
×
Mohs Surgery
×
Sarcoma
×
Clear all
NCT02310503
2020-05-05
REGESMOHS
Fundación Academia Española de Dermatología
Completed
6,000 enrolled